Variant report
Variant | nsv524688 |
---|---|
Chromosome Location | chr7:120305149-120327349 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:45)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:45 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BRCA1 | chr7:120321256-120321284 | GM12878 | blood: | n/a | n/a |
2 | CEBPB | chr7:120312042-120312225 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr7:120314216-120314533 | MCF-7 | breast: | n/a | n/a |
4 | CHD1 | chr7:120306405-120306414 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | E2F4 | chr7:120305179-120305191 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | EP300 | chr7:120314179-120314489 | MCF-7 | breast: | n/a | n/a |
7 | EP300 | chr7:120314140-120314641 | MCF-7 | breast: | n/a | n/a |
8 | FAM48A | chr7:120317096-120317154 | GM12878 | blood: | n/a | n/a |
9 | FAM48A | chr7:120323967-120324078 | GM12878 | blood: | n/a | n/a |
10 | GATA3 | chr7:120314128-120314756 | MCF-7 | breast: | n/a | n/a |
11 | GATA3 | chr7:120314161-120314601 | MCF-7 | breast: | n/a | n/a |
12 | GATA3 | chr7:120326878-120327023 | SH-SY5Y | brain: | n/a | n/a |
13 | HDAC2 | chr7:120314184-120314525 | MCF-7 | breast: | n/a | n/a |
14 | JUN | chr7:120319782-120319868 | K562 | blood: | n/a | n/a |
15 | MAFF | chr7:120305166-120305454 | HepG2 | liver: | n/a | n/a |
16 | MAFF | chr7:120319526-120319770 | HepG2 | liver: | n/a | chr7:120319627-120319641 chr7:120319628-120319646 |
17 | MAFF | chr7:120319508-120319705 | K562 | blood: | n/a | chr7:120319627-120319641 chr7:120319628-120319646 |
18 | MAFK | chr7:120321655-120321855 | HepG2 | liver: | n/a | n/a |
19 | MAFK | chr7:120319781-120319911 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | MAFK | chr7:120305151-120305470 | HepG2 | liver: | n/a | chr7:120305319-120305334 chr7:120305281-120305296 |
21 | MAFK | chr7:120319513-120319759 | IMR90 | lung: | n/a | chr7:120319624-120319644 chr7:120319632-120319646 chr7:120319626-120319642 |
22 | MAFK | chr7:120319519-120319741 | HepG2 | liver: | n/a | chr7:120319624-120319644 chr7:120319632-120319646 chr7:120319626-120319642 |
23 | MAFK | chr7:120305179-120305449 | HepG2 | liver: | n/a | chr7:120305319-120305334 chr7:120305281-120305296 |
24 | MAFK | chr7:120319493-120319770 | HepG2 | liver: | n/a | chr7:120319624-120319644 chr7:120319632-120319646 chr7:120319626-120319642 |
25 | MAFK | chr7:120321716-120321854 | HepG2 | liver: | n/a | n/a |
26 | MAX | chr7:120314086-120314491 | MCF-7 | breast: | n/a | n/a |
27 | MAZ | chr7:120311755-120311935 | HepG2 | liver: | n/a | n/a |
28 | MYC | chr7:120314179-120314314 | MCF-7 | breast: | n/a | n/a |
29 | NR2F2 | chr7:120314085-120314517 | MCF-7 | breast: | n/a | n/a |
30 | POLR2A | chr7:120326904-120326935 | MCF10A-Er-Src | breast: | n/a | n/a |
31 | POLR2A | chr7:120306194-120306385 | MCF10A-Er-Src | breast: | n/a | n/a |
32 | POLR2A | chr7:120312661-120312718 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | POLR2A | chr7:120309712-120309873 | ProgFib | skin: | n/a | n/a |
34 | POLR2A | chr7:120320657-120320671 | MCF10A-Er-Src | breast: | n/a | n/a |
35 | POLR2A | chr7:120308811-120308995 | MCF10A-Er-Src | breast: | n/a | n/a |
36 | RAD21 | chr7:120306610-120306905 | H1-hESC | embryonic stem cell: | n/a | chr7:120306710-120306720 |
37 | RAD21 | chr7:120306738-120306856 | H1-hESC | embryonic stem cell: | n/a | n/a |
38 | RFX5 | chr7:120322325-120322334 | K562 | blood: | n/a | n/a |
39 | RUNX3 | chr7:120321391-120321788 | GM12878 | blood: | n/a | chr7:120321622-120321631 chr7:120321646-120321655 chr7:120321646-120321655 |
40 | SIN3AK20 | chr7:120313970-120314692 | MCF-7 | breast: | n/a | n/a |
41 | STAT3 | chr7:120316348-120316394 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | STAT3 | chr7:120307049-120307051 | MCF10A-Er-Src | breast: | n/a | n/a |
43 | TCF12 | chr7:120313936-120314628 | MCF-7 | breast: | n/a | n/a |
44 | ZKSCAN1 | chr7:120323002-120323028 | Hela-S3 | cervix: | n/a | n/a |
45 | ZNF217 | chr7:120314313-120314458 | MCF-7 | breast: | n/a | n/a |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:120306644..120308434-chr7:120310032..120311976,2 | K562 | blood: | |
2 | chr7:120313871..120314817-chr7:120343491..120344070,2 | MCF-7 | breast: | |
3 | chr7:120306644..120308434-chr7:120310032..120311976,2 | K562 | blood: | |
4 | chr7:120313882..120314499-chr7:120360830..120361669,2 | MCF-7 | breast: | |
5 | chr7:120313917..120314645-chr7:120356906..120357867,3 | MCF-7 | breast: | |
6 | chr7:120299066..120301946-chr7:120309100..120311473,2 | K562 | blood: | |
7 | chr7:120297658..120300420-chr7:120317170..120319452,2 | K562 | blood: | |
8 | chr7:120323919..120325444-chr7:120328425..120329948,2 | K562 | blood: | |
9 | chr7:120312478..120314799-chr7:120323840..120326273,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNU6-581P | TF binding region |
ENSG00000252023 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs367951697 | chr7:120308844-120308845 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs139900076 | chr7:120308877-120308878 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs532006595 | chr7:120308905-120308906 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs548919241 | chr7:120308909-120308910 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs149834436 | chr7:120308958-120308959 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs539086949 | chr7:120309248-120309249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs534448567 | chr7:120309264-120309265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs559101345 | chr7:120309305-120309306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs570132796 | chr7:120309325-120309326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537724323 | chr7:120309336-120309337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs554476387 | chr7:120309339-120309340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574364774 | chr7:120309358-120309359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs117118687 | chr7:120309370-120309371 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113510656 | chr7:120309435-120309436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147103647 | chr7:120309443-120309444 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545927836 | chr7:120309515-120309516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556765101 | chr7:120309516-120309517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs181733519 | chr7:120309542-120309543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147563005 | chr7:120309551-120309552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141929544 | chr7:120309561-120309562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543646531 | chr7:120309590-120309591 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143086118 | chr7:120309632-120309633 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563413309 | chr7:120309635-120309636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375207794 | chr7:120309723-120309724 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs115213462 | chr7:120309770-120309771 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs185592022 | chr7:120309779-120309780 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs549892578 | chr7:120309934-120309935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531724662 | chr7:120309959-120309960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542572882 | chr7:120309960-120309961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs531442404 | chr7:120309993-120309994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565940080 | chr7:120309997-120309998 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs548075213 | chr7:120310021-120310022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs568218055 | chr7:120310023-120310024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs558893526 | chr7:120310068-120310069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs534099923 | chr7:120310071-120310072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553453205 | chr7:120310072-120310073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs570447960 | chr7:120310080-120310081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs539516876 | chr7:120310106-120310107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs549884829 | chr7:120310107-120310108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs60500498 | chr7:120310131-120310132 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs148228731 | chr7:120310175-120310176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542397513 | chr7:120310188-120310189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs147735804 | chr7:120311789-120311790 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs554037586 | chr7:120311809-120311810 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs573254583 | chr7:120311827-120311828 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs545194295 | chr7:120311830-120311831 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs557965394 | chr7:120311847-120311848 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs577949081 | chr7:120311855-120311856 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs559087270 | chr7:120311866-120311867 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs543732805 | chr7:120311867-120311868 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19401682 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:120309200-120310200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
2 | chr7:120314000-120315400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr7:120320600-120321600 | Enhancers | Adipose Nuclei | Adipose |
4 | chr7:120321200-120321400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr7:120321200-120321400 | Bivalent Enhancer | Primary hematopoietic stem cells | blood |
6 | chr7:120321200-120321600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr7:120321200-120321600 | Bivalent Enhancer | Primary monocytes fromperipheralblood | blood |
8 | chr7:120321200-120322000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
9 | chr7:120321200-120322000 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
10 | chr7:120321200-120322200 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
11 | chr7:120321400-120322000 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
12 | chr7:120321600-120322600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr7:120321800-120322600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr7:120322600-120323000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr7:120324000-120324800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr7:120324200-120324600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr7:120324200-120324800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
18 | chr7:120324600-120324800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
19 | chr7:120324600-120325000 | Enhancers | H1 Cell Line | embryonic stem cell |
20 | chr7:120324800-120332200 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |